{"id":"NCT01677624","sponsor":"Eisai Co., Ltd.","briefTitle":"A Multicenter, Open-label Study for E7040 in Japanese Subjects With Hypervascular Tumor and Subjects With Arteriovenous Malformation","officialTitle":"A Multicenter, Open-label Study for E7040 in Japanese Subjects With Hypervascular Tumor and Subjects With Arteriovenous Malformation","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-08","primaryCompletion":"2013-12","completion":"2014-03","firstPosted":"2012-09-03","resultsPosted":"2016-02-22","lastUpdate":"2016-02-22"},"enrollment":28,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hypervascular Tumor and Arteriovenous Malformation"],"interventions":[{"type":"DEVICE","name":"E7040","otherNames":[]}],"arms":[{"label":"E7040","type":"EXPERIMENTAL"}],"summary":"To evaluate the efficacy and safety of transcatheter arterial embolization with E7040 in Japanese subjects with hypervascular tumor or arteriovenous malformation","primaryOutcome":{"measure":"Success Rate of Embolization in the Target Vessel","timeFrame":"Day 1 (embolization) up to Day 30 after treatment","effectByArm":[{"arm":"Device E7040","deltaMin":100,"sd":null}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":10,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":28},"commonTop":["Post embolisation syndrome","Lymphocyte count decreased","Constipation","Aspartate aminotransferase increased","Nausea"]}}